Indivior PLC - Multiplikator Forward P/S INDV
Indivior PLC enjoys high physician trust and adheres to environmental standards in its packaging production. This forward price-to-sales chart reflects market expectations, with the current value standing at 2.40. A stable cash flow is driven by the long-term treatment of patients with addictions, providing the company with financial stability.
INDV (Indivior Corp): rincian analitis lan laporan miturut indikator
- rega saiki lan proyeksi nilai saham:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Indivior PLC|INDV - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Indivior PLC|INDV - Kewajiban utang agregat|Utang marang nilai buku Indivior Corp|INDV - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Indivior|Likuiditas cepet indivior.com
- indikator pendapatan resik lan kelipatan nilai:
INDV - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Indivior PLC|INDV - Koefisien rega marang bathi|Pangali Forward P/E Indivior Group|INDV - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Indivior Corp|INDV - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Indivior|INDV - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan indivior.com|INDV - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Indivior PLC
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analisis perusahaan:Indivior (INDV)
Indivior PLC revenues are subject to the influence of regulatory norms combating opioid addiction and patent risks. By analyzing the projected price-to-sales ratio, an investor assesses the company's market value relative to expected sales volume: an inflated multiple indicates a high premium for future growth, whereas low values confirm business stagnation or maturity.
Pesaing wigati
Multiplikator Forward P/S COLL (Collegium Pharmaceutical, Inc.)|CRON: Kapitalisasi marang prakiraan pendapatan|Tweed - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Canna Cabana HITI|ACB (auroramj.com) - Multiplikator forward rega marang pendapatan|ACHV (achievelifesciences.com) - Rasio rega marang prakiraan pendapatan|SKYE (Skye Bioscience) - Multiplikator Forward P/S|Anebulo Pharmaceuticals Inc (ANEB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan InterCure Ltd. (INCR)|NTRB - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Nasus Pharma NSRX|Rega forward marang dodolan IGC|MIRA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan FLGC (Flora Growth Corp)|imcannabis.com (IMCC) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ADIL (Adial Pharmaceuticals, Inc.)|Rasio rega marang prakiraan pendapatan Artelo Biosciences Inc.|Rasio rega marang prakiraan pendapatan ENSC|Multiplikator Forward P/S TTNP|Multiplikator forward rega marang pendapatan Greenlane Holdings, Inc. GNLN|Multiplikator Forward P/S INM (InMed Pharma)|Rasio kapitalisasi marang dodolan sing dikarepake Akanda Inc (AKAN)|ENVB - Rasio rega marang prakiraan pendapatan|BGXX (Bright Green) - Kapitalisasi marang prakiraan pendapatan|HPCO: Multiplikator Forward P/S
